Article
Cerebrospinal Fluid Biomarkers for Huntington’s Disease
31 Mar 2016
Abstract excerpt
Cerebrospinal fluid (CSF) is enriched in brain-derived components and represents an accessible and appealing means of interrogating the CNS milieu to study neurodegenerative diseases and identify biomarkers to facilitate the development of novel therapeutics. Many such CSF biomarkers have been proposed for Huntington's disease (HD) but none has been validated for clinical trial use. Across many studies proposing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
